Articles

RARECast Podcasts
July 1, 2022
Why Reforms to the Accelerated Approval Pathway Threaten Rare Disease Drug Development
Read More
Finance
July 1, 2022
X4 Pharmaceuticals Secures $55 Million Private Placement, Amends Debt Facility
Read More
Finance
June 30, 2022
Blueprint Medicines Enters $1.25 Billion Financing Collaborations with Sixth Street and Royalty Pharma
Read More
Deals
June 30, 2022
Sirana to Collaborate with Pfizer to Investigate Novel Treatment for Rare Bone Disease
Read More
Strategy
June 30, 2022
Avadel Cuts Costs to Pursue U.S. Marketing Approval of Narcolepsy Candidate
Read More
Drug Development
June 30, 2022
Angion Discontinues Phase 2 Study of Kidney Disease Therapy Candidate
Read More
Deals
June 30, 2022
C-Path and Replica Analytics Collaborate to Accelerate Rare Disease Research
Read More
Finance
June 29, 2022
ReCode Raises $120 Million to Expand LNP Delivery Platform and Diversify Pipeline
Read More
Finance
June 29, 2022
Catalyst Prepares to Liquidate, Will Distribute Cash to Stockholders
Read More
Drug Development
June 29, 2022
European Commission Approves First Treatment for ASMD
Read More

News

June 29, 2022
RARE Global Advocacy Alliance Member Spotlight: Ka...
Read More
June 23, 2022
Overcoming My Struggles And Becoming Resilient Wit...
Read More
June 22, 2022
Can Chronic Pain Change your Personality?
Read More
June 3, 2022
RARE Drug Development Symposium: Emerging Models &...
Read More
June 3, 2022
RARE Drug Development Symposium: Fostering Succes...
Read More
Read more
X